Altesa BioSciences, Inc.

Amendment

CIK: 0001960618·Pharmaceuticals·DELAWARE·Filed: Jul 7, 2023

Total Offering

$35,000,000

Amount Sold

$35,000,000

Investors

18

First Sale

Dec 22, 2022

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2020
Non-Accredited Investors: No

Related Persons

Name	Role
John Clerici	Related Person
Brett Giroir	Related Person
Seth Rudnick	Related Person
Ittai Harel	Related Person
Moncef Slaoui	Related Person
Nicholas Williams	Related Person

Company

Altesa BioSciences, Inc.

1930 HARVARD AVENUE

COLLEGE PARK, GA, 30337

703-795-4274

SEC Filing

0001960618-23-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.